AstraZeneca Pharma India financials at a glance

+ Portfolio

The revenue of AstraZeneca Pharma India is reported as 8.31809 billion Rupees in the fiscal year 2020. The earnings were 28.68 Rupees per share in 2020, which was 31.68 higher than 2019. And about -0.1422 billion Rupees are reported as free cash flow in the financials of AstraZeneca Pharma India 2020. Dividends of 0 Rupees per share were paid to shareholders of AstraZeneca Pharma India stock BSE:506820 in fiscal 2020.

Forecast

Financials

Year	Year	TTM	2020	2019	2011
Rev.	Revenue	N/A	Rp8.32B	Rp7.28B	Rp5.74B
GM %	Gross Margin %	62.44%	62.53%	67.35%	67.90%
OM	Operating Margin	17.60%	12.33%	7.77%	16.29%
EPS	Earnings Per Share	Rp61.12	Rp28.68	Rp21.78	Rp25.65
Div.	Dividends	N/A	Rp0.00	Rp0.00	Rp0.00
PR %	Payout Ratio %	0	0	0	0
Sha.	Shares	N/AM	25M	25M	25M
OCF	Operating Cash Flow	N/A	Rp0.00M	Rp0.00M	Rp0.00M
FCF	Free Cash Flow	N/A	Rp0.00M	Rp0.00M	Rp0.00M
FCFS	Free Cash Flow Per Share	Rp25.57	Rp29.28	Rp14.52	Rp10.31

AstraZeneca Pharma India financials at a glance

Financials

Discover